Diagnosis And Management Of Diarrhea In Solid‐Organ Transplant Recipients
Publication Date: April 1, 2019
Recommendations
EPIDEMIOLOGY AND ETIOLOGY OF DIARRHEA IN SOT RECIPIENTS
A detailed clinical history should be obtained on all SOT recipients presenting with diarrhea. (Moderate, Strong)
317067
Clinicians must have heightened suspicion for infection as a cause of diarrhea in SOT recipients. (Moderate, Strong)
317067
Clinicians should be aware of regional differences in the etiology of diarrhea in SOT recipients, and diagnostic and treatment strategies should be individualized for the specific practice region. (High, Strong)
317067
DIAGNOSTIC EVALUATION
Initial testing for SOT recipients with diarrhea should include testing for C. difficile and bacterial pathogens in the stool and CMV PCR testing in the serum. (Moderate, Strong)
317067
All patients with diarrhea should have their medications reviewed for potential causes of diarrhea and unnecessary agents should be stopped. (Moderate, Strong)
317067
SOT recipients with fever and bloody diarrhea should be evaluated for invasive enteropathogens and CMV. (Moderate, Strong)
317067
Persistent diarrhea should prompt testing for norovirus and parasitic causes for diarrhea. (Moderate, Strong)
317067
Colonoscopy with or without biopsy should be performed on SOT recipients with chronic diarrhea that have had a negative infectious evaluation or for those not responding to targeted therapy. (Moderate, Strong)
317067
If available, multiplex PCR testing for stool pathogens should be performed on all SOT recipients presenting with diarrhea.
(Moderate, Weak)317067
TREATMENT
Empiric antimotility therapy should be considered in SOT recipients with diarrhea that is negative for C. difficile and where there is no evidence of megacolon or inflammatory diarrhea. (Moderate, Weak)
317067
SOT recipients with diarrhea and mild to moderate dehydration should be given reduced osmolarity rehydration fluids. (Moderate, Strong)
317067
Isotonic intravenous fluids should be administered for those with severe dehydration, shock, altered mental status, or ileus. (High, Strong)
317067
Antimicrobial therapy should be modified to target any identified pathogen suspected to be the cause of the diarrhea. (High, Strong)
317067
Title
Diagnosis And Management Of Diarrhea In Solid‐Organ Transplant Recipients
Authoring Organization
American Society of Transplantation
Publication Month/Year
April 1, 2019
External Publication Status
Published
Country of Publication
US
Document Objectives
These guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation review the diagnosis, prevention, and management of diarrhea in the pre‐ and post‐transplant period.
Target Patient Population
Solid organ transplant patients
Inclusion Criteria
Female, Male, Adolescent, Adult, Older adult
Health Care Settings
Ambulatory, Hospital, Operating and recovery room, Outpatient
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Diagnosis, Prevention, Management, Treatment
Diseases/Conditions (MeSH)
D003967 - Diarrhea, D019072 - Antibiotic Prophylaxis, D014180 - Transplantation, D019737 - Transplants, D016377 - Organ Transplantation, D016360 - Clostridium difficile, D029322 - Norovirus
Keywords
diarrhea, Clostridium difficile, infection, solid organ transplant, antimicrobial, norovirus
Source Citation
Angarone, M, Snydman, DR; on behalf of the AST ID Community of Practice. Diagnosis and management of diarrhea in solid‐organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33:e13550.